Concourse Financial Group Securities, Inc. Surmodics Inc Transaction History
Concourse Financial Group Securities, Inc.
- $1.64 Billion
- Q3 2024
Number of Shares
0
Previous 0
NaN%
Holding current value
$0
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
26 transactions
Others Institutions Holding SRDX
# of Institutions
128Shares Held
13.2MCall Options Held
25.5KPut Options Held
3.4K-
Beryl Capital Management LLC Redondo Beach, CA1.54MShares$59.2 Million25.28% of portfolio
-
Black Rock Inc. New York, NY1.17MShares$45 Million0.0% of portfolio
-
Morgan Stanley New York, NY1.12MShares$42.9 Million0.0% of portfolio
-
Trigran Investments, Inc.1.04MShares$40.1 Million4.59% of portfolio
-
Vanguard Group Inc Valley Forge, PA804KShares$30.9 Million0.0% of portfolio
About SURMODICS INC
- Ticker SRDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 14,005,000
- Market Cap $538M
- Description
- Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...